These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23438652)

  • 1. Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy.
    Hojan K; Milecki P; Molińska-Glura M; Roszak A; Leszczyński P
    Eur J Phys Rehabil Med; 2013 Jun; 49(3):331-9. PubMed ID: 23438652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical activity and body composition, body physique, and quality of life in premenopausal breast cancer patients during endocrine therapy--a feasibility study.
    Hojan K; Molińska-Glura M; Milecki P
    Acta Oncol; 2013 Feb; 52(2):319-26. PubMed ID: 23193959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of aerobic exercises on bone mineral density in breast cancer women during endocrine therapy.
    Hojan K; Milecki P; Leszczyński P
    Pol Orthop Traumatol; 2013 Feb; 78():47-51. PubMed ID: 23369864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
    Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
    Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study.
    Hadji P; Kauka A; Ziller M; Birkholz K; Baier M; Muth M; Kann P
    Breast Cancer Res Treat; 2014 Apr; 144(2):343-51. PubMed ID: 24519387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
    Gnant MF; Mlineritsch B; Luschin-Ebengreuth G; Grampp S; Kaessmann H; Schmid M; Menzel C; Piswanger-Soelkner JC; Galid A; Mittlboeck M; Hausmaninger H; Jakesz R;
    J Clin Oncol; 2007 Mar; 25(7):820-8. PubMed ID: 17159195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.
    Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
    J Womens Health (Larchmt); 2019 Jan; 28(1):87-92. PubMed ID: 30312118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy.
    Park IH; Ro J; Lee KS; Kim EA; Kwon Y; Nam BH; Jung SY; Lee S; Kim SW; Kang HS
    J Clin Oncol; 2010 Jun; 28(16):2705-11. PubMed ID: 20421538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
    Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
    J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study.
    Lohman T; Going S; Pamenter R; Hall M; Boyden T; Houtkooper L; Ritenbaugh C; Bare L; Hill A; Aickin M
    J Bone Miner Res; 1995 Jul; 10(7):1015-24. PubMed ID: 7484276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
    Sverrisdottir A; Nystedt M; Johansson H; Fornander T
    Breast Cancer Res Treat; 2009 Oct; 117(3):561-7. PubMed ID: 19153828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detraining reverses positive effects of exercise on the musculoskeletal system in premenopausal women.
    Winters KM; Snow CM
    J Bone Miner Res; 2000 Dec; 15(12):2495-503. PubMed ID: 11127215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
    Pfeiler G; Königsberg R; Fesl C; Mlineritsch B; Stoeger H; Singer CF; Pöstlberger S; Steger GG; Seifert M; Dubsky P; Taucher S; Samonigg H; Bjelic-Radisic V; Greil R; Marth C; Gnant M
    J Clin Oncol; 2011 Jul; 29(19):2653-9. PubMed ID: 21555684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.
    Schwartz AL; Winters-Stone K; Gallucci B
    Oncol Nurs Forum; 2007 May; 34(3):627-33. PubMed ID: 17573321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between body composition and bone mineral density in healthy premenopausal women].
    Liu JM; Zhao HY; Ning G; Zhang LZ; Xu MY; Chen JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):250-3. PubMed ID: 12905733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer.
    Bartsch R; Bago-Horvath Z; Berghoff A; DeVries C; Pluschnig U; Dubsky P; Rudas M; Mader RM; Rottenfusser A; Fitzal F; Gnant M; Zielinski CC; Steger GG
    Eur J Cancer; 2012 Sep; 48(13):1932-8. PubMed ID: 22459763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.
    Sverrisdottir A; Johansson H; Johansson U; Bergh J; Rotstein S; Rutqvist L; Fornander T
    Breast Cancer Res Treat; 2011 Aug; 128(3):755-63. PubMed ID: 21625929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
    McCune JS; Games DM; Espirito JL
    J Oncol Pharm Pract; 2005 Jun; 11(2):37-43. PubMed ID: 16460603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study evaluating the association of purposeful physical activity, body fat distribution, and steroid hormones on premenopausal breast cancer risk.
    Kumar NB; Riccardi D; Cantor A; Dalton K; Allen K
    Breast J; 2005; 11(4):266-72. PubMed ID: 15982394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.